Healthcare >> CEO Interviews >> October 14, 2002
ROBERT ROBB is President, Chief Executive Officer and co-Founder of
Quorex Pharmaceuticals, Inc. Mr. Robb has a diverse background as
business developer, executive manager, and seed venture capitalist. Mr.
Robb has served as President and Director of several biotechnology
startups. He is serving on the Boards of Directors of two early-stage
companies, Epeius Biotechnology, Inc., and Mpex Bioscience, Inc. During
the past 18 years he has been involved in launching, funding and/or
managing over 20 early stage, bioscience/healthcare enterprises,
including Zonagen, Gene Medicine, Cardiogene, Hepatix (Vitagen),
Matrigen, and Genosys. Immediately prior to joining Quorex in 1999, Mr.
Robb was President and co-Founder of BioVentures West, a San Diego
venture capital company, which he managed for two years in partnership
with Research Corporation Technologies, Inc. Prior to BioVentures West,
he managed spinoff activities for the University of Michigan as Director
of the Technology Management Office and served as Director of Business
Development at BCM Technologies, Inc., a subsidiary of Baylor College of
Medicine. Mr. Robb also founded InMedica Development Corporation, a
public venture capital company that funded and assisted emerging
companies, and for four years directed the investment of its capital
into life science enterprises. Mr. Robb has a BS degree in Environmental
Biology and a Master of Science degree in Parasitology/Microbiology from
the University of Utah. Profile
Pharmaceuticals, and then a picture of things as they are now?
Mr. Robb: Quorex began back in 1999. We launched the company as an
